Lanreotide depot deep subcutaneous injection: a new method of delivery and its associated benefits
about
Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease.Building Nanostructures with Drugs.Pharmacoeconomic aspects of the treatment of pituitary gland tumours.Patient-focussed outcomes in acromegaly.Attitudes and preferences in patients with acromegaly on long-term treatment with somatostatin analogues.Emerging drugs for acromegaly.A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry.Lanreotide for the treatment of gastroenteropancreatic neuroendocrine tumors.Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism.The care continuum in acromegaly: how patients, nurses, and physicians can collaborate for successful treatment experiences.
P2860
Q33702355-6B86AF61-A217-4C2C-ACAF-2B908C6F0A26Q36766960-8C8109F8-D851-42D8-87D4-493E4A3326C6Q36936833-D20460D1-26A9-4274-995D-053A727FD6A7Q37530996-0C7C7998-BC49-4AF9-BE69-DE3F6ED33E71Q37641076-077A0CD0-D70A-4F4C-A52B-480549786235Q38176659-16B5FA29-CA8B-463E-A7DB-06847B07C70CQ38373377-DB070A3B-A398-4FA8-8A09-9D7DA4588122Q38658730-64BD36AC-2A15-402E-A5AA-03EA188F7CF2Q42098360-B1AE0F35-B27A-439A-9E2F-C9434FD097F1Q42414991-B2C21AFB-D4A0-496D-8355-E302072B4BB2
P2860
Lanreotide depot deep subcutaneous injection: a new method of delivery and its associated benefits
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lanreotide depot deep subcutan ...... ry and its associated benefits
@en
Lanreotide depot deep subcutan ...... y and its associated benefits.
@nl
type
label
Lanreotide depot deep subcutan ...... ry and its associated benefits
@en
Lanreotide depot deep subcutan ...... y and its associated benefits.
@nl
prefLabel
Lanreotide depot deep subcutan ...... ry and its associated benefits
@en
Lanreotide depot deep subcutan ...... y and its associated benefits.
@nl
P2860
P356
P1476
Lanreotide depot deep subcutan ...... ry and its associated benefits
@en
P2093
John D Carmichael
P2860
P356
10.2147/PPA.S20783
P407
P577
2012-01-18T00:00:00Z